| Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study. | |
| | |
MedLine Citation:
|
PMID: 20347079 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To compare the efficacy of Crinone vaginal gel and intramuscular progesterone (IMP) for luteal phase support in in vitro fertilization-embryo transfer (IVF-ET) with respect to pregnancy rates and outcomes, and to assess patient satisfaction with both products. DESIGN: Prospective randomized trial. SETTING: University-affiliated IVF unit. PATIENT(S): Women under age 40 years with day-3 follicle-stimulating hormone levels <15 mIU/mL undergoing their first, second, or third IVF cycles on gonadotropin releasing-hormone (GnRH) down-regulation protocols. INTERVENTION(S): Luteal phase supplementation with either Crinone vaginal gel or IMP; phone survey regarding patient satisfaction with Crinone vaginal gel and IMP. MAIN OUTCOME MEASURE(S): Pregnancy rates, ongoing/delivered, failed pregnancy rates, and product satisfaction scores for patients supplemented with Crinone vaginal gel and with IMP. RESULT(S): Four hundred sixty-eight patients were randomized, and 407 completed the study. The patients were randomized on the day of oocyte retrieval to receive either Crinone vaginal gel or IMP for luteal phase support. Pregnancy, ongoing/delivered, and failed pregnancy rates were similar between the Crinone and IMP treatment arms (OR [95% CI]: 1.2 [0.8, 1.8], 1.1 [0.8, 1.7], 1.0 [0.6, 1.7], respectively). On a scale of 1 to 5, patient satisfaction scores were statistically significantly higher with Crinone vaginal gel than with IMP (4.4 ± 0.9 vs. 2.8 ± 1.2). CONCLUSION(S): Crinone vaginal gel and IMP are equally effective for luteal phase support in IVF, but Crinone is better tolerated by patients. |
| | |
Authors:
|
Elena Yanushpolsky; Shelley Hurwitz; Louise Greenberg; Catherine Racowsky; Mark Hornstein |
Related Documents
:
|
20940289 - Indications and maternofetal outcome of instrumental deliveries at the university teach... 19943809 - Laboratory reference intervals during pregnancy, delivery and the early postpartum period. 7088429 - Symptomatic intrauterine retention of fetal bones. 12047309 - The term breech presentation. a retrospective study with regard to the planned mode of ... 6477849 - Should a paediatrician be present at non-rotational forceps deliveries? 6529959 - Childbirth in true hermaphrodite. 11512499 - Asthma in pregnancy. 3514949 - Sonographic assessment of the endometrium in patients undergoing in vitro fertilization. 1833609 - Ethical considerations relating to prenatal diagnosis of fetuses with down syndrome. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't Date: 2010-03-27 |
Journal Detail:
|
Title: Fertility and sterility Volume: 94 ISSN: 1556-5653 ISO Abbreviation: Fertil. Steril. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-26 Completed Date: 2011-01-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372772 Medline TA: Fertil Steril Country: United States |
Other Details:
|
Languages: eng Pagination: 2596-9 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115-6114, USA. eyanushpolsky@partners.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Embryo Transfer* / methods Female Fertilization in Vitro* / methods Humans Injections, Intramuscular Luteal Phase / drug effects* Patient Satisfaction Pregnancy Pregnancy Rate Progesterone / administration & dosage*, adverse effects*, analogs & derivatives* Progesterone Congeners / administration & dosage, adverse effects Treatment Outcome Vaginal Creams, Foams, and Jellies |
| Chemical | |
Reg. No./Substance:
|
0/Crinone; 0/Progesterone Congeners; 0/Vaginal Creams, Foams, and Jellies; 57-83-0/Progesterone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hysteroscopic management of heterotopic cesarean scar pregnancy.
Next Document: OCT4 gonadal gene expression related to the presence of Y-chromosome sequences in Turner syndrome.